Klearman Micki 4
4 · Kezar Life Sciences, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Klearman Micki
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-15+35,000→ 35,000 totalExercise: $2.64Exp: 2033-06-14→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]One-hundred percent (100%) of the shares subject to the option shall vest on 6/15/2024, subject to Reporting Person continuing to provide service through such date.